C07D 265/32
With oxygen atoms directly attached to ring carbon atoms
Official title: with oxygen atoms directly attached to ring carbon atoms
C07D265/32 (With oxygen atoms directly attached to ring carbon atoms) appears on 344 US grants and 241 published applications in this corpus.
Search patents in C07D- Granted patents
- 344
- Published applications
- 241
- Assignees
- 206
- Inventors
- 876
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 11 | 0 |
| 1978 | 14 | 0 |
| 1979 | 3 | 0 |
| 1980 | 7 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 3 | 0 |
| 1986 | 7 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 6 | 0 |
| 1991 | 4 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 20 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 10 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 12 | 0 |
| 2002 | 17 | 16 |
| 2003 | 15 | 10 |
| 2004 | 4 | 7 |
| 2005 | 4 | 11 |
| 2006 | 3 | 13 |
| 2007 | 4 | 9 |
| 2008 | 3 | 3 |
| 2009 | 6 | 4 |
| 2010 | 10 | 18 |
| 2011 | 4 | 12 |
| 2012 | 6 | 5 |
| 2013 | 6 | 18 |
| 2014 | 6 | 9 |
| 2015 | 9 | 15 |
| 2016 | 17 | 16 |
| 2017 | 10 | 16 |
| 2018 | 16 | 12 |
| 2019 | 10 | 6 |
| 2020 | 6 | 11 |
| 2021 | 4 | 2 |
| 2022 | 7 | 7 |
| 2023 | 2 | 9 |
| 2024 | 3 | 6 |
| 2025 | 4 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Amino acid- , peptide- and polypeptide-lipids, isomers, compositions, and uses thereof9 Jun 2026US 12,648,959 B2Massachusetts Institute of Technology
- Silicon compound and method of manufacturing integrated circuit device using the same9 Jun 2026US 12,649,716 B2Dnf Co., Ltd.
- Compounds useful for inhibiting RAF dimers14 Oct 2025US 12,440,494 B2Albert Einstein College of Medicine
- Compounds and compositions for intracellular delivery of therapeutic agents2 Sep 2025US 12,404,232 B2ModernaTX, Inc.
- Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors17 Jun 2025US 12,331,024 B2Gen1E Lifesciences Inc.
- Inhibitors and uses thereof23 Jul 2026US 2026/0207621 A1Vividion Therapeutics, Inc.
- Compounds and compositions for intracellular delivery of therapeutic agents19 Mar 2026US 2026/0078082 A1ModernaTX, Inc.
- Methods for producing viloxazine salts and novel polymorphs thereof8 Jan 2026US 2026/0008759 A1Supernus Pharmaceuticals, Inc.
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium25 Sep 2025US 2025/0299695 A1Resonac Corporation
- Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors28 Aug 2025US 2025/0270176 A1Gen1E Lifesciences Inc.
Most cited
By later US patents
- Amide complexes151US 5,693,310 ASchering Corporation · 1997
- Bupropion metabolites and methods of use151US 6,342,496 B12002
- Compounds with activity on muscarinic receptors147US 6,528,529 B1ACADIA Pharmaceuticals Inc. · 2003
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Species-linked diamine triacetic acids and their chelates123US 4,352,751 AAnalytical Radiation Corporation · 1982